LEADER 01782oam  2200457   450 
001 9910704129103321
005 20160414150431.0
035   $a(CKB)5470000002438376
035   $a(OCoLC)932206109
035   $a(EXLCZ)995470000002438376
100   $a20151215d2015      ua             0
101 0 $aeng
135   $aurbn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aExamining medical product development in the wake of the Ebola epidemic $ehearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, November 19, 2014
210  1$aWashington :$cU.S. Government Publishing Office,$d2015.
215   $a1 online resource (iii, 130 pages) $cillustrations
300   $aTitle from title screen (viewed on Dec. 15, 2015).
300   $aPaper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office.
300   $a"Serial No. 113-182."
517   $aExamining medical product development in the wake of the Ebola epidemic 
606   $aEbola virus disease$xPrevention
606   $aEbola virus disease$xTreatment
606   $aMedical supplies$xGovernment policy$zUnited States
608   $aLegislative hearings.$2lcgft
615  0$aEbola virus disease$xPrevention.
615  0$aEbola virus disease$xTreatment.
615  0$aMedical supplies$xGovernment policy
801  0$bGPO
801  1$bGPO
801  2$bSTF
801  2$bOCLCO
801  2$bCOO
801  2$bOCLCO
801  2$bGPO
906   $aBOOK
912   $a9910704129103321
996   $aExamining medical product development in the wake of the Ebola epidemic$93459269
997   $aUNINA